Markets:

Overview

News

Currencies

International

Treasuries

Inspire Medical Systems, Inc. Common Stock (NY:INSP)

128.11 -2.28 (-1.75%)

Streaming Delayed Price Updated: 12:33 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inspire Medical Systems, Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

United Therapeutics, Super Micro Computer, Novo Nordisk And Other Big Gainers From Wednesday ↗

November 03, 2022

U.S. stocks closed lower on Wednesday, with the Dow Jones dropping more than 500 points. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

Earnings Preview For Inspire Medical Systems ↗

October 31, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems: Q2 Earnings Insights ↗

August 02, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Inspire Medical Systems Earnings Preview ↗

August 01, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems: Q1 Earnings Insights ↗

May 03, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Inspire Medical Systems's Earnings Outlook ↗

May 02, 2022

Inspire Medical Systems (NYSE:INSP) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

Inspire Medical Systems Stock Scores Relative Strength Rating Upgrade ↗

April 20, 2022

Inspire Medical System stock reached an key technical benchmark, seeing its Relative Strength (RS) Rating jumping to 91.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2022 ↗

April 13, 2022

Upgrades

Via Benzinga

Executive Chairman Bill Ford Continues To Buy More Ford Shares ↗

April 04, 2022

I was recently listening to Barry’s Ritholtz’s Masters in Business podcast interview with Darren Palmer, the VP of Ford’s Global EV Program, and he...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022 ↗

April 06, 2022

Upgrades

Via Benzinga

Executives Sell Over $640M Of 5 Stocks ↗

March 30, 2022

Although oil futures traded higher on Wednesday, there were a few notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects...

Via Benzinga

Inspire Medical Clocks 70% Increase In Q4 Sales, Issues FY22 Guidance Ahead Of Consensus ↗

February 09, 2022

Inspire Medical Systems Inc (NYSE: INSP) generated revenue of

Via Benzinga

Inspire Medical Systems: Q4 Earnings Insights ↗

February 08, 2022

Inspire Medical Systems (NYSE:INSP) reported its Q4 earnings results on Tuesday, February 8, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar ↗

February 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets ↗

January 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Annexon Announces Mixed Phase 2 Data From Huntington Disease Trial Annexon,...

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More ↗

February 06, 2022

Biotech stocks managed to close the week ending Feb. 4 with gains. Stocks recovered along with the broader markets early in the week, but came under pressure midweek amid negative reaction to some big...

Via Benzinga

Inspire Medical Expects Strong Q4 FY21 Revenue Growth ↗

January 05, 2022

Inspire Medical Systems Inc (NYSE: INSP) expects Q4 FY21 revenue of $78.0 million - $78.4 million, up approximately 70% Y/Y and surpassing the consensus estimate of $65...

Via Benzinga

A Peek Into The Markets: US Stock Futures Mixed After Dow Records Another High ↗

January 05, 2022

Pre-open movers U.S. stock futures traded mixed in early pre-market trade after the Dow Jones surged to a new record closing high on Tuesday. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch For January 5, 2022 ↗

January 05, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.83 per share on revenue of...

Via Benzinga

Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023

November 04, 2021

Palm Beach, FL – November 4, 2021 – FinancialNewsMedia.com News Commentary – Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of...

Via FinancialNewsMedia

Topics Death

Inspire Medical Systems, inc (INSP) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

INSP earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

Analyst Ratings For Inspire Medical Systems ↗

September 24, 2021

Analysts have provided the following ratings for Inspire Medical Systems (NYSE:IN...

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

September 24, 2021

Telsey Advisory Group reduced the price target for NIKE, Inc. (NYSE: NKE) from $180 to $176. NIKE shares fell 4.6% to $152.26 in pre-market trading. Wedbush raised the price...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data ↗

September 23, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (...

Via Benzinga

Looking into Inspire Medical Systems's Return on Capital Employed ↗

August 20, 2021

After pulling data from Benzinga Pro it seems like during Q2, Inspire Medical Systems (NYSE:INSP) posted sales of $52.96 million. Earnings were up 20.05%, but Inspire Medical...

Via Benzinga

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical ↗

August 31, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

88 Biggest Movers From Yesterday ↗

August 05, 2021

Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in...

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.